Donald Weaver

Dr. Donald Weaver


Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2005 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
IGIan Gilron
Ian Gilron
JBJoan M. Bailey
Joan M. Bailey
DTDongsheng Tu
Dongsheng Tu
RHRonald R. Holden
Ronald R. Holden
DWDonald Weaver
Donald Weaver
RHRobyn L. Houlden
Robyn L. Houlden
The available drugs to treat neuropathic pain have incomplete efficacy and dose-limiting adverse effects. We compared the efficacy of a combination of gabapentin and morphine with that of each as a single agent in patients with painful diabetic neuropathy or postherpetic neuralgia.

11 October 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MGMayuri Gupta
Mayuri Gupta
HLHyeok Jun Lee
Hyeok Jun Lee
CBChristopher J. Barden
Christopher J. Barden
DWDonald Weaver
Donald Weaver

1 October 2010 in Neurochemistry International
Verified
Journal Article
Closed access
KTK.E. Tiedje
K.E. Tiedje
KSK. Stevens
K. Stevens
SBS. Barnes
S. Barnes
DWDonald Weaver
Donald Weaver

21 October 2003 in Journal of Chemical Information and Computer Sciences
Verified
Journal Article
Closed access
JSJeffrey J. Sutherland
Jeffrey J. Sutherland
LOLee A. O'Brien
Lee A. O'Brien
DWDonald Weaver
Donald Weaver

21 September 2004 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JSJeffrey J. Sutherland
Jeffrey J. Sutherland
LOLee A. O'BRien
Lee A. O'BRien
DWDonald Weaver
Donald Weaver

1 September 2010 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
MCM D Carter
M D Carter
GSG A Simms
G A Simms
DWDonald Weaver
Donald Weaver